Delivery Order SPE2DB22D9239-SPE2DB24FDD68

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) by the Defense Logistics Agency. This order is being issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical products to the Defense Logistics Agency with a potential value of up to five million dollars through December 2025. Under this particular...

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) by the Defense Logistics Agency to provide forty-five hundred sixty-three thousand one hundred forty vials of XENPOZYME 20 MG. The delivery order was awarded on December 6, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical products...

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) by the Defense Logistics Agency to provide forty-five hundred sixty-three thousand ten vials of XENPOZYME 20 MG. The place of performance will be Park Ridge, Illinois and all work must be completed by December 18, 2023. As a woman-owned small business, DMS Pharmaceutical Group holds an indefinite delivery contract with the...

The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $72,848 delivery order contract to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the firm fixed price contract, DMS will provide 4562192625 units of 20 mg vials of XENPOZYME pharmaceutical product to the DLA. Performance will take place at the contractor's facility in Park Ridge and span from September 1st through September 25th, 2023. No subcontractors or set aside...

The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) to DMS Pharmaceutical Group Inc. The order is for twenty thousand four hundred (20,400) vials of XENPOZYME, a twenty milligram medication, to be delivered to a facility in Park Ridge, Illinois by September 27, 2023 in support of DLA's medical supply procurement...

The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XENPOZYME 20 mg vials. The $109,272.60 contract has a completion date of March 19, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and generic drugs to government agencies, particularly the Department of Veterans Affairs and Department of...

The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) to DMS Pharmaceutical Group Inc. to supply twenty thousand (20,000) units of XENPOZYME 20 MG VIALS. Performance will take place in Park Ridge, Illinois under a start date of August 2, 2023 and end date of August 23, 2023. As a key logistics combat support agency within the Department of Defense, the Defense Logistics Agency...

This federal contract award, valued at $109,272.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The delivery order contract is for the supply of XENPOZYME 20 MG VIALS, with a performance period through May 2, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, contract 4600082013 under the DLA's SPE2DB program, valued at up to $4,999,999 through the end of...

This is a $87,418.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award covers the delivery of XENPOZYME 20 MG VIALS, a specialized pharmaceutical product, with a period of performance through February 10, 2023. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $109,272.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of XENPOZYME 20 MG VIALS and has an ultimate completion date of April 15, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which is valued at up...